1700001J03Rik Activators
1700001J03Rik Activators encompass a diverse group of chemical compounds that facilitate the functional enhancement of 1700001J03Rik through specific and varied signaling mechanisms. Compounds like Forskolin and IBMX effectively increase intracellular cAMP levels, thereby activating protein kinase A (PKA), which is known to phosphorylate a broad range of substrates. This phosphorylation cascade can extend to 1700001J03Rik, increasing its activity within its signaling pathway. Similarly, activators such as Phorbol 12-myristate 13-acetate (PMA) directly stimulate protein kinase C (PKC), which may lead to the phosphorylation and subsequent activation of 1700001J03Rik, assuming it is a substrate of PKC. The chemical class identified as 1700001J03Rik Activators comprises a series of compounds that specifically target and augment the activity of the protein encoded by the 1700001J03Rik gene. These activators are distinguished by their molecular configurations which enable them to engage with the protein in a way that promotes its biological function. The interaction is not merely a matter of binding; it is the precision with which these molecules fit into the protein's structure that determines their efficacy. When these activators bind to the 1700001J03Rik protein, they can induce conformational changes that either trigger or enhance the protein's intrinsic activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to increased cAMP levels, which supports the PKA pathway, thereby potentially enhancing the phosphorylation and activation of 1700001J03Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may reduce competitive kinase activity, allowing 1700001J03Rik to act more efficiently within its signaling pathway. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors that can initiate signaling cascades, which in turn may upregulate the functional activity of 1700001J03Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can phosphorylate and activate downstream proteins, potentially enhancing the activity of 1700001J03Rik if it is a PKC substrate. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can alter signaling pathways and potentially enhance the activity of 1700001J03Rik by reducing negative feedback regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which could shift the signaling balance in favor of pathways that enhance the activity of 1700001J03Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, which may redirect signaling through alternative routes that enhance the activity of 1700001J03Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases intracellular calcium levels, potentially enhancing the activity of 1700001J03Rik if it is regulated by calcium-dependent pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can reduce competitive signaling, possibly allowing for enhanced activity of 1700001J03Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Despite being a broad-spectrum kinase inhibitor, staurosporine may selectively enhance pathways that activate 1700001J03Rik by inhibiting kinases that negatively regulate 1700001J03Rik. | ||||||